Delphia (USA)’s Labcorp LH Stock Holding History

Delphia (USA)’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,279	Closed	-$259K	–	303
2022 Q4	$259K	Buy	+1,279	New	+$250K	0.3%	149
2022 Q3	–	Sell	-1,275	Closed	-$257K	–	363
2022 Q2	$257K	Sell	1,275 -182	-12%	-$38.8K	0.18%	215
2022 Q1	$330K	Buy	+1,457	New	+$343K	0.25%	156

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Delphia (USA)'s LH Position: Q1 2023 in Review

Delphia (USA) sold out of Labcorp (LH) in Q1 2023, closing a stake of 1,279 shares — an estimated $259K sold.

Delphia (USA) first reported a position in LH in Q1 2022 and held it in 3 quarters. The position peaked at $330K in Q1 2022. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

Delphia (USA) reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
Delphia (USA) sold 1,279 Labcorp shares in Q1 2023, an estimated $259K.
Delphia (USA) first reported a position in Labcorp in Q1 2022 and held it in 3 quarters.
Delphia (USA)'s Labcorp position peaked at $330K in Q1 2022.
940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Delphia (USA)'s 13F filing for Q1 2023, filed 15 May 2023.